BACKGROUND. To the authors' knowledge, an association between adult T-
cell leukemia/lymphoma (ATL) and acute myeloid leukemia (AML) has been
reported only in four patients. The authors identified five additiona
l patients with both neoplasms. METHODS. A review of the clinical reco
rds of patients with AML, ATL, or lymphoid neoplasms other than ATL di
agnosed between 1986 and 1995 was performed. Cytokine levels were assa
yed in selected patients. The authors searched for reports from other
institutions using MEDLINE and the proceedings of two Japanese hematol
ogy societies. RESULTS. ATL was diagnosed in 134 patients, whereas 180
had AML. Five patients with both neoplasms were identified (3.7% of A
TL patients and 2.8% of AML patients). In seven of the nine patients (
including four patients in the literature) with ATL and AML, the ATL w
as diagnosed prior to the AML, whereas in the remaining two patients b
oth neoplasms were diagnosed simultaneously. Six of the nine cases wer
e therapy-related (t)-AML, which developed after chemotherapy for ATL.
Monoclonal integration of proviral human T-lymphotropic virus type 1
was detected in ATL cells but not in AML cells in the six patients exa
mined. The plasma levels of macrophage colony-stimulating factor (M-CS
F), granulocyte-colony stimulating factor, and granulocyte-macrophage-
colony stimulating factor (GM-CSF) were elevated in 3, 1, and 1, respe
ctively, of the 4 patients examined at AML onset who had active ATL. I
n one case, the levels of several cytokines, including GM-CSF and M-CS
F, in the supernatant fluid of short term cultured ATL cells were elev
ated. Three patients with de novo ATL and AML received remission induc
tion therapy, and two achieved a complete remission (CR) of both disea
ses. Among the four patients who received chemotherapy for t-AML, two
achieved CR. CONCLUSIONS. ATL patients also can develop AML, irrespect
ive of treatment with chemotherapy for ATL. This association does not
indicate exclusive chemoresistance of both neoplasms. Cytokines produc
ed by ATL cells may support the growth of AML cells. (C) 1998 American
Cancer Society.